DDW event focusses on rAAVs and long-read nanopore sequencing
Drug Discovery World
APRIL 17, 2024
Join DDW for this exclusive free event, ‘ rAAV genome sequencing with Oxford Nanopore uncovers transgene integrity and packaging impurities ’. The event will be supported by Oxford Nanopore Technologies. Recombinant adeno-associated viruses (rAAVs) are considered a promising delivery system for gene therapy medicines.
Let's personalize your content